Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Ethena (ENA) vs Injective (INJ) Price & Performance

EthenaTrade
InjectiveTrade

Price performance (Past 24H)

Key statistics

Ethena vs Injective — how do they compare? Ethena trades at Rp1,512 (market cap Rp14,46T, Rp2,21T 24h volume), while Injective trades at Rp92,698 (market cap Rp9,29T, Rp1,78T 24h volume). The key difference: Ethena is the larger of the two by market cap, and Ethena's supply is capped (9,6B / 15B ENA (64%)) while Injective's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Ethena for 43 Days and Injective for 36 Days on average.

ENAINJ
Market Cap
Rp14,46TRp9,29T
Volume (24h)
Rp2,21TRp1,78T
Circulating Supply
9,6B / 15B ENA (64%)100M INJ
Typical Hold Time
43 Days36 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Ethena

Ethena (ENA) is trading at Rp1,527 with a market cap of Rp14.55 trillion, showing bullish technical signals from moving averages despite neutral oscillators. The token has 64% of its 15 million max supply in circulation, with an average hold time of 43 days. Recent on-chain activity indicates steady network participation, though no major protocol upgrades have been reported recently.

Overall outlook is cautiously optimistic given technical strength, but investors should monitor overbought RSI levels and key resistance at Rp1,570. Major risks include typical crypto volatility and regulatory uncertainties, while opportunities lie in potential ecosystem growth and increased adoption if trading volumes sustain.

Injective

Injective (INJ) is trading at Rp92,221 with a market cap of Rp9.18T, showing a bullish technical signal overall. The moving averages are strongly bullish, while oscillators are neutral. Key resistance lies at Rp93,589 and support at Rp86,188. The asset has a hold time of 36 days, indicating moderate holding behavior. No major protocol updates or ecosystem news are noted recently, but the token remains active in decentralized exchange and DeFi sectors.

Overall outlook is cautiously optimistic due to bullish technicals, but risks include high volatility and neutral oscillators suggesting potential consolidation. Opportunities lie in continued ecosystem growth, while major risks involve crypto market sentiment shifts and regulatory uncertainties. Investors should monitor key resistance levels for breakout signals.

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

ENA
76% Buy24% Sell
Avg holding period · 43 Days
INJ
29% Buy71% Sell
Avg holding period · 36 Days

Top news

Latest headlines on both assets

About Ethena

Ethena is a synthetic dollar protocol built on Ethereum that will provide a crypto-native solution for money that is not reliant on traditional banking system infrastructure, alongside a globally accessible dollar-denominated savings instrument — the 'Internet Bond'.

Read more on ENA

About Injective

Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.

Read more on INJ